Across TCGA patient cohorts, SLC22A20P mutation is significantly associated with the immune_cell of many other genes, with 7 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SLC22A20P-associated genes across cancer lineages are MPP, CD4+ Tcm, and Erythrocytes. Each is linked with SLC22A20P in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC22A20P-to-partner and partner-to-SLC22A20P results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC22A20P→partner) and Y-score (partner→SLC22A20P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	MPP →	+0.016	+2.233	.042	.045	3	2
BLCA	CD4+ Tcm →	+0.020	+3.527	.036	.033	3	1
UCEC	Erythrocytes →	+0.021	+3.180	.028	.010	3	1
UCEC	Astrocytes →	-0.037	-1.825	.040	.033	3	1
UCEC	Mesangial cells →	-0.049	-2.491	.001	.002	3	1
UCEC	Basophils →	+0.138	+1.584	.038	.037	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 7 associations by consensus.

Exploration

SLC22A20P survival (RNA) · tumor vs normal (RNA) · all SLC22A20P data types